We are pleased to announce that CompagOs is now officially an ETH Zurich spin-off. ETH Zurich is one of the world’s best universities and the institution with the highest number of spin-offs in Switzerland. As an ETH spin-off, we gain access to a robust network of resources, expertise, and support, which will further propel our mission to empower researchers to translate findings to clinical applications and enable doctors to match patients with the right treatments at the right time.